Patient-reported symptoms in predicting the subsequent progression of chronic health conditions among childhood cancer survivors
Open Access
- 24 March 2026
- journal article
- research article
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Abstract
Background Childhood cancer survivors frequently develop chronic medical conditions long after treatment. Patient-reported symptoms may provide early signals of deteriorating health, but their prognostic value for later disease progression remains unclear. We aim to determine whether symptom patterns and their changes over time are associated with the progression of chronic health conditions in adult survivors of childhood cancer. Methods We analyzed 735 survivors enrolled in the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort Study who completed three symptom assessments and repeated standardized clinical evaluations. Symptoms were grouped into physical and emotional dimensions to classify survivors into four clusters from low to high burden. Changes in symptom burden over time were also classified. Progression of total and organ-specific chronic health conditions was determined from clinical assessments. Statistical models evaluated associations between symptom patterns and subsequent disease progression after adjustment for demographic, lifestyle, and treatment factors. Results Here, we show that survivors with high physical and emotional symptom burden had higher risks of progression of total chronic health conditions and of respiratory, musculoskeletal, neurologic, and endocrine conditions. Survivors with increasing or persistently high symptom burden over time also had greater progression of total and organ-specific conditions, including neurologic, respiratory, endocrine, and reproductive outcomes. Conclusions These findings show that symptom patterns provide prognostic information beyond treatment history and identify survivors at elevated risk for worsening health. Integrating routine symptom monitoring into survivorship care may enable earlier detection of disease progression and support more personalized preventive care.Keywords
All Related Versions
Funding Information
- National Cancer Institute (R21CA202210)
- National Cancer Institute (R01CA238368)
- National Cancer Institute (R01CA258193)
- National Cancer Institute (U01CA195547)
- National Cancer Institute (R01CA238368)
- National Cancer Institute (U24CA055727)
- National Cancer Institute (U01CA195547)
- National Cancer Institute (R21CA202210)
This publication has 41 references indexed in Scilit:
- Symptom Screening for Hospitalized Pediatric Patients With CancerJAMA Pediatrics, 2025
- Multilevel Characteristics of Cumulative Symptom Burden in Young Survivors of Childhood CancerJAMA Network Open, 2024
- Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohortThe Lancet, 2023
- Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization GroupThe Lancet Oncology, 2023
- Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic reviewThe Lancet Oncology, 2019
- Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970–99: a report from the Childhood Cancer Survivor Study cohortThe Lancet Oncology, 2018
- The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)The Lancet, 2017
- Factors associated with childhood cancer survivors’ knowledge about their diagnosis, treatment, and risk for late effectsJournal of Cancer Survivorship, 2015
- Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood CancerJAMA, 2007
- Brief Symptom Inventory-182000